Skip to main content

UBS Group AG

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in ZVRA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,076,918
-$1,856,569 QoQ
Shares Held
144,834
-65.7% QoQ
Ownership
0.244%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 158 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. ZVRA ranks #212 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ZVRA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,076,918 144,834
2026-03-31 $3,933,487 422,048
2025-12-31 $2,557,971 285,488
2025-09-30 $2,074,092 218,096
2025-06-30 $1,358,361 154,184
2025-03-31 $1,221,349 163,064
2024-12-31 $2,867,442 343,818
2024-09-30 $138,341 19,934
2024-06-30 $63,366 12,932
2024-03-31 $249,098 42,948
2023-12-31 $229,970 35,110
2023-09-30 $90,336 18,742
2023-06-30 $102,469 20,092
2023-03-31 $22,764 4,139
2022-12-31 $32,042 6,981
2022-09-30 $6,096 977
2022-06-30 $25,859 5,798
2021-12-31 $91,445 10,499
2021-03-31 $122,203 13,283